Echeminfo Applications of Cheminformatics and Chemical Modelling to Drug Discovery
8-19 November 2004
echeminfo.com
Conference Co-Chairs:
David Llyod David Lloyd Brad Feuston Brad Feuston Barry Hardy Barry Hardy
1. Perspectives on Cheminformatics & Modelling, Barry Hardy, Douglas Connect
Stephen Whiteley Stephen Whiteley, LION Bioscience
Compound optimization tools: Designed by scientists for scientists
Peter Murray-Rust Peter Murray-Rust, University of Cambridge
Chemical Markup Language - where Open Source and Open Data meet
Henry Rzepa Henry Rzepa, Imperial College London
The Chemical Semantic Web: publishing & CMLRSS
Kim Henrick Kim Henrick, European Bioinformatics Insititute
MSDsite: behind the scene: The technology used in database searching and retrieval for the analysis and viewing of bound ligands and active sites
Jeff Spitzner Jeff Spitzner, Rescentris
Collaborative knowledge integration: enabling semantic exchange of research

2. Libraries, Victor Lobanov, Johnson & Johnson
Greg Landrum Greg Landrum, Rational Discovery,
Predictive models for CDK2 inhibition: Using crystal structures, machine learning, and novel pharmacophore descriptors to build models for library design
Santosh Puttta Santosh Putta, Rational Discovery,
Designing better libraries using active learning: Performance of different library-design strategies in a simulated CDK2 drug discovery program.
Alan Gibbs Alan Gibbs, Johnson & Johnson,
Enhancing the Diversity of a Corporate Collection - Strategies from a Recent Acquisition

3. Screening & Docking, John Irwin, UCSF
Darryl Reid Darryl Reid, Simbiosys,
Enrichment and cross-validation studies of the eHiTS high throughput screening software package
and
Zsolt Zsoldos Zsolt Zsoldos, Simbiosys,
Enrichment and cross-validation studies of the eHiTS high throughput screening software package
Miklos Vargyas Miklos Vargyas, Chemaxon,
Screening a Virtual Compound Space
 

Chenglong Li, Scripps,
Successful Virtual Screening for Human AICAR Transformylase Inhibitors against NCI Diversity set Using AutoDock

Peter Willet Peter Willet, University of Sheffield,
Virtual screening using binary kernel discrimination
Andreas Bender Andreas Bender, University of Cambridge,
Virtual Screening Using Atom Environments and Surface Point Environments (MOLPRINT) – Evaluation of Complementary 2D and 3D Methods
  Robert Brown, Scitegic,
Application of Novel Structural Fingerprints and Bayesian Learning to HTS Data Mining and Screening Prioritization
Matthew Jacobson Matthew P. Jacobson, UCSF,
Physics-Based Computational Methods for Drug Design

4. QSAR, David Lloyd, Trinity College Dublin
Paul Blower Paul Blower, Leadscope,
Correlating gene expression with classes of cytotoxic agents: identifying substrates and inhibitors of mdr1
Michael Bolger

Michael B. Bolger, Simulations Plus, Inc.,
ADMET Predictions by Linking QSPR and Simulation

Curt Breneman Curt Breneman Rensselaer Polytechnic Institute (NY),
Graphical and automated analysis of the chemical information within hybrid shape/property descriptors in kernel-based models with feature selection

5. Quality Control in Model Development, Alex Tropsha, UNC
Robert Clark Bob Clark, Tripos,
Non-parametric Methods for Identifying the Robust QSAR Models
Paola Gramatica Paola Gramatica, University of Insubria, Different approaches to QSAR models' validation
Joseph Votano Joseph R. Votano, ChemSilico, New Neural Net Based Predictors for Several ADME/Tox Properties: Aqueous Solubility, % Human Oral Absorption, and GenoTox (Ames) using Topological Descriptors

6. Drug Design, Brad Feuston, Merck
Szabolcs Csepregi Szabolcs Csepregi, Chemaxon, Advanced structural searching using ChemAxon Tools
Martin Slater Martin Slater, Biofocus, Thematic analysis (a chemoproteomic approach), Application to GPCR's and Ion channels
Philip Dean Philip Dean, De Novo Pharmaceuticals, Ligand-based de novo Design Techniques
Chris Culberson Chris Culberson, Merck, Binding model of the HERG channel
7. QM/MM, Adrian Mulholland, University of Bristol
Ken Merz Ken Merz Penn State and QuantumBio,
Quantum Mechanics for Drug Discovery
and
Lance Westerhoff Lance Westerhoff, Penn State and QuantumBio
Quantum Mechanics for Drug Discovery
Adrian Mulholland Adrian Mulholland, University of Bristol,
Analysing enzyme activity and specificity by QM/MM modelling
Darrin York Darrin York, University of Minnesota,
Simulations of phosphoryl transfer reactions using new hybrid quantum mechanical/molecular mechanical methods
Richard Bryce Richard Bryce, University of Manchester,
Towards quantum mechanical force fields for biomolecules
Harald Lanig Harald Lanig, Erlangen University,
The application of QM/MM techniques to model enzyme mechanisms and protein-ligand interactions

8. Open Source, Garrett Morris, Scripps
Jesus Castagnetto Jesus Castagnetto, University of California San Diego,
Made with Open Source: Lessons learned while building the MDB
Joerg Wegner Joerg Wegner, University of Tuebingen,
JOELib - An open source chemoinformatics library for data mining on molecular structures
Michael Love Michael Love, John Hopkins School of Medicine ,
ADP-Ribosyl Cyclase: the story of crystallographic computing on a novel free software platform
Michel Sanner Michel Sanner, The Scripps Research Institute,
Python-based software components for structural bioinformatics
Tim Aitken Tim Aitken, Accelrys,
Accord: Cheminformatics tools for open development

9. Grid Computing, Barry Hardy, Douglas Connect
Rajkumar Buyya Rajkumar Buyya, University of Melbourne,
BioGrid: Distributed Molecular Modelling for Drug Design on the World-Wide Grid
Putchong Uthayopas Putchong Uthayopas, Thai Grid Project,
Combining the Power of Multiple Clusters for Virtual Screening using Grid Technology

10. Protein Modelling, David Lloyd, Trinity College Dublin
Nikolay Dokholyan Nikolay V. Dokholyan, UNC,
Reconstructing evasive protein states using NMR and molecular modeling: the Focal Adhesion Kinase story
Jed Pitera Jed Pitera, IBM Almaden,
Protein modelling: simulating the thermodynamics and kinetics of protein folding
Peter Winn Peter Winn, European Molecular Biology Laboratory,
Determinants of Functionality in the Ubiquitin Conjugating Enzyme Family
Marc Fasnacht Marc Fasnacht, Columbia University,
Automated Methods for identifying Structural Motifs: Helix Couples in the Globins

11. Modelling of Membranes and Ion Channels, Richard Pastor, FDA CBER
Tom Woolf Tom Woolf, Johns Hopkins University, School of Medicine,
Emerging approaches to computation of peptide folding, electrified interfaces and drug binding for biomembrane systems
Anna Skibinsky Anna Skibinsky, Center for Biologics Evaluation & Research, FDA,
The Search for Trehalose's Function in Lipid Bilayers
Andrew Pohorille Andrew Pohorille, NASA Ames Research Center,
Structure, Function, Self-assembly and Origin of Simple Membrane Proteins
Max Berkowitz Max Berkowitz, UNC,
Complexes Between Lipids in Bilayers
Scott Feller Scott Feller, Wabash College,
Understanding the Unique Properties of Polyunsaturated Lipids
Emad Tajkhorshid Emad Tajkhorshid, Beckman Institute, University of Illinois at Urbana-Champaign, Computational Studies of Permeation and Selectivity of Membrane Channels
Indira Chandrasekhar Indira Chandrasekhar, Swiss Federal Institute of Technology Zurich,
Membrane Simulation: Parameterisation and Application
  Gerhard Hummer, National Institutes of Health,
Simulation of Nucleic Acid Transport Through Carbon Nanotube Membranes